Journal News

Rethinking how culture medium contributes to cellular function

Isha Dey
Jan. 4, 2022

Cell culture medium, as we know, contains a combination of growth factors and other components that help researchers grow cells in the lab. An important constituent in the growth medium is serum, an animal-derived complex of growth factors, amino acids and lipids, which provides nutrition to the growing cells. Researchers lack complete information on serum composition and its lot-to-lot variability but have studied the effects of some growth medium components on cellular metabolism. However, they do not yet understand fully the impact of the medium’s lipid content on cell function.

The powerhouse of human cells is mitochondria. An important component that determines mitochondrial function is cardiolipins, or CLs. These phospholipids located on the inner mitochondrial membrane are involved in mitochondrial bioenergetics and maintaining architecture of the mitochondrial membranes as well as in scavenging reactive oxygen species. However, cardiolipin composition is different in different tissues of the body, and because CLs play a central role in mitochondrial function, this means cells in different organs have varied mitochondrial activity.

To better understand the effect of nutrition, especially lipids, on mitochondrial CL composition and function, Markus Keller’s lab at the Medical University of Innsbruck in Austria cultured mammalian cells in lipid-free medium and then fed them with various types of lipids. Using mass spectrometry lipidomics and mathematical modeling, the authors were able to quantify the CL composition in the presence of different fatty acids in the growth medium.

Specifically, addition of linoleic acid to the medium altered 76% of the natural CL side chain composition compared to untreated medium. Addition of alpha linolenic acid and arachidonic acid also altered CL side chain composition significantly. Moreover, linoleic acid treatment increased the activity of the mitochondrial respiratory complex I, which is responsible for generating ATP and thus regulates normal functioning of a cell. The lab’s breakthrough findings were published in the Journal of Lipid Research.

Gregor Oemer, the first author on the paper, said an initial challenge of this project was finding cells that would grow without lipids, which are usually necessary for cell proliferation. “We got Panserin 401 (a serum-free medium) from a German biotech company and luckily got our HeLa cells to grow in this lipid-free medium,” he said.

The work was a collaborative effort. “We were in luck because Innsbruck is the home base for Oroboros, one of the most renowned respirometry companies,” Oemer said, “and thanks to Erich Gnaiger, the head, we collaborated for the respirometry assays.”

This project was a continuation of Oemer’s master’s thesis from the Keller lab. “Lipid metabolism is very complex but quite fascinating, and we don’t know much about it,” he said.

What struck Oemer most was how, by just altering the lipid intake, the researchers were able to influence critical cellular functions. He hopes the work raises awareness that variations in serum in cell culture medium may alter experimental data. This is especially important while studying diseases such as Barth syndrome, a genetic disorder characterized by abnormalities in mitochondrial cardiolipins.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Isha Dey

Isha Dey is a scientist at Thermo Fisher Scientific.

Related articles

From the journals: JLR
Swarnali Roy
From the journals: JLR
Swarnali Roy
From the journals: JLR
Nivedita Uday Hegdekar
From the journals: JLR
Clementine Adeyemi
From the journals: JLR
Lisa Learman & Laurel Oldach

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
News

Cracking cancer’s code through functional connections

July 2, 2025

A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.